Anticonvulsive properties of soticlestat, a novel cholesterol 24-hydroxylase inhibitor.
Saved in:
| Title: | Anticonvulsive properties of soticlestat, a novel cholesterol 24-hydroxylase inhibitor. |
|---|---|
| Authors: | Nishi T; Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan., Metcalf CS; Department of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA., Fujimoto S; Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan., Hasegawa S; Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan., Miyamoto M; Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan., Sunahara E; Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan., Watanabe S; Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan., Kondo S; Neuroscience Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Fujisawa, Japan., White HS; Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington, USA. |
| Source: | Epilepsia [Epilepsia] 2022 Jun; Vol. 63 (6), pp. 1580-1590. Date of Electronic Publication: 2022 Mar 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1528-1167 |
|---|---|
| DOI: | 10.1111/epi.17232 |
